Cite
HARVARD Citation
Signorelli, M. et al. (2020). Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy. Journal of cachexia, sarcopenia and muscle. 11 (2), pp. 505-517. [Online].